Researchers are studying the mechanisms of immune escape and immunotherapy resistance in tumors, with various factors such as MYC, STAT3, and tryptophan metabolism being investigated. The role of these factors at the tumor-immune interface is being explored for potential therapeutic opportunities. Different studies are examining various aspects of tumor biology and antitumor immunity, including the effects of certain enzymes and cellular processes on immune escape and immunotherapy.